Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Schipper

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.
The Lancet. Oncology|December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1John R Prensner, Shuang Zhao, Nicholas Erho, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
European Urology|January 8, 2018
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall SurvivalWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2024
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung CancerDonna M Edwards, Caitlin A Schonewolf, John D Rice, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate CancerLiat Hammer, Ralph Jiang, Jason Hearn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck CancerMichelle L Mierzwa, Madhava Aryal, Choonik Lee, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.
The Lancet. Oncology|December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1John R Prensner, Shuang Zhao, Nicholas Erho, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
European Urology|January 8, 2018
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall SurvivalWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2024
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung CancerDonna M Edwards, Caitlin A Schonewolf, John D Rice, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate CancerLiat Hammer, Ralph Jiang, Jason Hearn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck CancerMichelle L Mierzwa, Madhava Aryal, Choonik Lee, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
Pageof 9